Skip to content

Insider · CIK 0001398625

David S Snyder

cfoofficer

Files at COYA (Coya Therapeutics, Inc.). First filing Nov 14, 2024, latest Nov 14, 2024.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
1 / 0
$13k bought, $0 sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

COYA: Coya Therapeutics, Inc.

COYAOct 9, 2026 · close 4.95

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
43Moderate
COYAbuy 3
Coya Therapeutics, Inc.
$13k
1,800 shares
+26%-

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Jan 9, 2025COYA
Coya Therapeutics, Inc.
AGrant or award
Stock Option (right to buy)derivative
+140,562$0.00$0140,562Jan 13, 2025
Nov 14, 2024COYA
Coya Therapeutics, Inc.
POpen-market purchase
Common Stock, par value $0.0001 per share
+1,800$7.19$13k8,800Nov 14, 2024

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

David S Snyder: insider trades and track record | InsiderTell